EXOC1_HUMAN - dbPTM
EXOC1_HUMAN - PTM Information in dbPTM
Basic Information of Protein
UniProt ID EXOC1_HUMAN
UniProt AC Q9NV70
Protein Name Exocyst complex component 1
Gene Name EXOC1
Organism Homo sapiens (Human).
Sequence Length 894
Subcellular Localization Midbody, Midbody ring . Cytoplasm . Cytoplasm, perinuclear region . Colocalizes with CNTRL/centriolin at the midbody ring.
Protein Description Component of the exocyst complex involved in the docking of exocytic vesicles with fusion sites on the plasma membrane.; (Microbial infection) Has an antiviral effect against flaviviruses by affecting viral RNA transcription and translation through the sequestration of elongation factor 1-alpha (EEF1A1). This results in decreased viral RNA synthesis and decreased viral protein translation..
Protein Sequence MTAIKHALQRDIFTPNDERLLSIVNVCKAGKKKKNCFLCATVTTERPVQVKVVKVKKSDKGDFYKRQIAWALRDLAVVDAKDAIKENPEFDLHFEKIYKWVASSTAEKNAFISCIWKLNQRYLRKKIDFVNVSSQLLEESVPSGENQSVTGGDEEVVDEYQELNAREEQDIEIMMEGCEYAISNAEAFAEKLSRELQVLDGANIQSIMASEKQVNILMKLLDEALKEVDQIELKLSSYEEMLQSVKEQMDQISESNHLIHLSNTNNVKLLSEIEFLVNHMDLAKGHIKALQEGDLASSRGIEACTNAADALLQCMNVALRPGHDLLLAVKQQQQRFSDLRELFARRLASHLNNVFVQQGHDQSSTLAQHSVELTLPNHHPFHRDLLRYAKLMEWLKSTDYGKYEGLTKNYMDYLSRLYEREIKDFFEVAKIKMTGTTKESKKFATLPRKESAVKQETESLHGSSGKLTGSTSSLNKLSVQSSGNRRSQSSSLLDMGNMSASDLDVADRTKFDKIFEQVLSELEPLCLAEQDFISKFFKLQQHQSMPGTMAEAEDLDGGTLSRQHNCGTPLPVSSEKDMIRQMMIKIFRCIEPELNNLIALGDKIDSFNSLYMLVKMSHHVWTAQNVDPASFLSTTLGNVLVTVKRNFDKCISNQIRQMEEVKISKKSKVGILPFVAEFEEFAGLAESIFKNAERRGDLDKAYTKLIRGVFVNVEKVANESQKTPRDVVMMENFHHIFATLSRLKISCLEAEKKEAKQKYTDHLQSYVIYSLGQPLEKLNHFFEGVEARVAQGIREEEVSYQLAFNKQELRKVIKEYPGKEVKKGLDNLYKKVDKHLCEEENLLQVVWHSMQDEFIRQYKHFEGLIARCYPGSGVTMEFTIQDILDYCSSIAQSH
Overview of Protein Modification Sites with Functional and Structural Information
Experimental Post-Translational Modification Sites

* ASA = Accessible Surface Area

Locations Modification Substrate Peptides
&
Secondary Structure
ASA (%) Reference Orthologous
Protein Cluster
5Acetylation---MTAIKHALQRDI
---CCHHHHHHHCCC
21.9919608861
5Malonylation---MTAIKHALQRDI
---CCHHHHHHHCCC
21.9926320211
22PhosphorylationPNDERLLSIVNVCKA
CCHHHHHHHHHHHHC
29.1428122231
28AcetylationLSIVNVCKAGKKKKN
HHHHHHHHCCCCCCC
56.7625953088
28MalonylationLSIVNVCKAGKKKKN
HHHHHHHHCCCCCCC
56.7626320211
34MalonylationCKAGKKKKNCFLCAT
HHCCCCCCCEEEEEE
68.7626320211
41PhosphorylationKNCFLCATVTTERPV
CCEEEEEEECCCCCE
19.8620068231
43PhosphorylationCFLCATVTTERPVQV
EEEEEEECCCCCEEE
20.7020068231
44PhosphorylationFLCATVTTERPVQVK
EEEEEECCCCCEEEE
26.1720068231
85UbiquitinationVDAKDAIKENPEFDL
ECHHHHHHHCCCCCC
53.83-
117AcetylationAFISCIWKLNQRYLR
HHHHHHHHHHHHHHH
20.0425953088
160PhosphorylationDEEVVDEYQELNARE
CHHHHHHHHHHCHHH
11.6527642862
288 (in isoform 2)Ubiquitination-37.0521906983
288 (in isoform 1)Ubiquitination-37.0521906983
288MalonylationDLAKGHIKALQEGDL
HHHHHHHHHHHHCCC
37.0526320211
288UbiquitinationDLAKGHIKALQEGDL
HHHHHHHHHHHHCCC
37.05-
297PhosphorylationLQEGDLASSRGIEAC
HHHCCCCHHHCHHHH
28.0629255136
298PhosphorylationQEGDLASSRGIEACT
HHCCCCHHHCHHHHH
28.9929255136
337PhosphorylationKQQQQRFSDLRELFA
HHHHHHHHHHHHHHH
37.6124719451
397PhosphorylationKLMEWLKSTDYGKYE
HHHHHHHCCCCCCCC
25.0820068231
398PhosphorylationLMEWLKSTDYGKYEG
HHHHHHCCCCCCCCC
31.4920068231
400PhosphorylationEWLKSTDYGKYEGLT
HHHHCCCCCCCCCCC
18.6620068231
402UbiquitinationLKSTDYGKYEGLTKN
HHCCCCCCCCCCCHH
33.62-
441UbiquitinationTGTTKESKKFATLPR
ECCCHHHHCCCCCCC
53.66-
445PhosphorylationKESKKFATLPRKESA
HHHHCCCCCCCCHHH
40.1928348404
448 (in isoform 2)Phosphorylation-59.4930266825
449 (in isoform 2)Phosphorylation-54.8230266825
451PhosphorylationATLPRKESAVKQETE
CCCCCCHHHHHHHHH
41.2029496963
453 (in isoform 2)Phosphorylation-10.2826434776
455 (in isoform 2)Phosphorylation-57.1325849741
456 (in isoform 2)Phosphorylation-49.1526434776
457 (in isoform 2)Phosphorylation-28.5125849741
457PhosphorylationESAVKQETESLHGSS
HHHHHHHHHHHCCCC
28.5128985074
458 (in isoform 2)Phosphorylation-51.0225849741
459PhosphorylationAVKQETESLHGSSGK
HHHHHHHHHCCCCCE
32.8425849741
463PhosphorylationETESLHGSSGKLTGS
HHHHHCCCCCEECCC
25.7725849741
464PhosphorylationTESLHGSSGKLTGST
HHHHCCCCCEECCCC
44.5325849741
468PhosphorylationHGSSGKLTGSTSSLN
CCCCCEECCCCHHHC
32.3530266825
470PhosphorylationSSGKLTGSTSSLNKL
CCCEECCCCHHHCCE
21.6329255136
471PhosphorylationSGKLTGSTSSLNKLS
CCEECCCCHHHCCEE
24.5529255136
472PhosphorylationGKLTGSTSSLNKLSV
CEECCCCHHHCCEEE
34.2329255136
473PhosphorylationKLTGSTSSLNKLSVQ
EECCCCHHHCCEEEC
35.7329255136
478PhosphorylationTSSLNKLSVQSSGNR
CHHHCCEEECCCCCC
21.5128152594
481PhosphorylationLNKLSVQSSGNRRSQ
HCCEEECCCCCCCCC
37.7530266825
482PhosphorylationNKLSVQSSGNRRSQS
CCEEECCCCCCCCCC
24.0130266825
487PhosphorylationQSSGNRRSQSSSLLD
CCCCCCCCCCCCCHH
31.0425159151
489PhosphorylationSGNRRSQSSSLLDMG
CCCCCCCCCCCHHCC
24.1223401153
490PhosphorylationGNRRSQSSSLLDMGN
CCCCCCCCCCHHCCC
19.8525159151
491PhosphorylationNRRSQSSSLLDMGNM
CCCCCCCCCHHCCCC
37.8925159151
499PhosphorylationLLDMGNMSASDLDVA
CHHCCCCCHHHCCHH
28.7230266825
501PhosphorylationDMGNMSASDLDVADR
HCCCCCHHHCCHHCH
31.2525159151
509PhosphorylationDLDVADRTKFDKIFE
HCCHHCHHHHHHHHH
36.2923403867
544PhosphorylationFKLQQHQSMPGTMAE
HHHHHCCCCCCCCCE
25.4829255136
548PhosphorylationQHQSMPGTMAEAEDL
HCCCCCCCCCEEECC
13.8229255136
559PhosphorylationAEDLDGGTLSRQHNC
EECCCCCCCCCCCCC
27.3929255136
561PhosphorylationDLDGGTLSRQHNCGT
CCCCCCCCCCCCCCC
29.7229255136
568PhosphorylationSRQHNCGTPLPVSSE
CCCCCCCCCCCCCCH
24.6926657352
609PhosphorylationDKIDSFNSLYMLVKM
CHHHHHHHHHHHHHH
20.9023663014
611PhosphorylationIDSFNSLYMLVKMSH
HHHHHHHHHHHHHHC
6.5523663014
635PhosphorylationPASFLSTTLGNVLVT
HHHHHHHCCCCHHHE
29.3224532841
642PhosphorylationTLGNVLVTVKRNFDK
CCCCHHHEEECCHHH
19.0224532841
649UbiquitinationTVKRNFDKCISNQIR
EEECCHHHHHHHHHH
29.36-
687PhosphorylationEFAGLAESIFKNAER
HHHHHHHHHHHHHHH
27.9324719451
700AcetylationERRGDLDKAYTKLIR
HHHCCHHHHHHHHHH
51.0612432695
702PhosphorylationRGDLDKAYTKLIRGV
HCCHHHHHHHHHHHH
15.3322817900
703PhosphorylationGDLDKAYTKLIRGVF
CCHHHHHHHHHHHHC
25.0021955146
704AcetylationDLDKAYTKLIRGVFV
CHHHHHHHHHHHHCC
29.2825953088
704MalonylationDLDKAYTKLIRGVFV
CHHHHHHHHHHHHCC
29.2826320211
722AcetylationKVANESQKTPRDVVM
HHCCCCCCCHHHEEH
70.5425953088
769PhosphorylationHLQSYVIYSLGQPLE
HHHHHHHHHCCCCHH
6.4422817900
799PhosphorylationGIREEEVSYQLAFNK
CCCHHHHHHHHHCCH
15.50-
800PhosphorylationIREEEVSYQLAFNKQ
CCHHHHHHHHHCCHH
16.8428796482

Upstream regulatory proteins (kinases for phosphorylation sites, E3 ubiquitin ligases of ubiquitination sites, ...)
Modified Location Modified Residue Modification Type of Upstream Proteins Gene Name of Upstream Proteins UniProt AC of Upstream Proteins Sources

Oops, there are no upstream regulatory protein records of EXOC1_HUMAN !!

Functions of PTM Sites
Modified Location Modified Residue Modification Function Reference

Oops, there are no descriptions of PTM sites of EXOC1_HUMAN !!

Disease-associated PTM Sites based on SAP

* Distance = the distance between SAP position and PTM sites.

Modified Location Modification Variant Position
(Distance <= 10)
Residue Change SAP Related Disease Reference

Oops, there are no SNP-PTM records of EXOC1_HUMAN !!

Protein-Protein Interaction
Interacting Protein Gene Name Interaction Type PPI Reference Domain-Domain Interactions
TRIO_HUMANTRIOphysical
17043677
CDC5L_HUMANCDC5Lphysical
17043677
DYST_HUMANDSTphysical
17043677
LC7L2_HUMANLUC7L2physical
17043677
EXOC4_HUMANEXOC4physical
17043677
SYBU_HUMANSYBUphysical
17043677
SPTN1_HUMANSPTAN1physical
17043677
SFR1_HUMANSFR1physical
17043677
CCSE2_HUMANCCSER2physical
17043677
CCD93_HUMANCCDC93physical
17043677
GRDN_HUMANCCDC88Aphysical
17043677
KDM1A_HUMANKDM1Aphysical
17043677
NUF2_HUMANNUF2physical
17043677
MACF1_HUMANMACF1physical
17043677
SRGP2_HUMANSRGAP2physical
17043677
GOGA4_HUMANGOLGA4physical
17043677
3BP5_HUMANSH3BP5physical
17043677
CE295_HUMANCEP295physical
17043677
K1551_HUMANKIAA1551physical
17043677
KIF5A_HUMANKIF5Aphysical
17043677
TRIM9_HUMANTRIM9physical
17043677
KANL1_HUMANKANSL1physical
17043677
COL12_HUMANCOLEC12physical
17043677
EXOC4_HUMANEXOC4physical
19889837
RUBIC_HUMANKIAA0226physical
21241894
RBCC1_HUMANRB1CC1physical
21241894
BAKOR_HUMANATG14physical
21241894
EXOC2_HUMANEXOC2physical
26344197
EXOC3_HUMANEXOC3physical
26344197
EXOC4_HUMANEXOC4physical
26344197
NCK5L_HUMANNCKAP5Lphysical
28514442
TUFT1_HUMANTUFT1physical
28514442
GRAP1_HUMANGRIPAP1physical
28514442
GOGA4_HUMANGOLGA4physical
28514442
CLOCK_HUMANCLOCKphysical
28514442
EXOC2_HUMANEXOC2physical
28514442
FKB15_HUMANFKBP15physical
28514442
CAVN1_HUMANPTRFphysical
28514442
BL1S4_HUMANBLOC1S4physical
28514442
EXOC4_HUMANEXOC4physical
28514442
RABE2_HUMANRABEP2physical
28514442
RBG10_HUMANRABGAP1Lphysical
28514442
RBG1L_HUMANRABGAP1Lphysical
28514442
NDC80_HUMANNDC80physical
28514442
PF21A_HUMANPHF21Aphysical
28514442
EXC6B_HUMANEXOC6Bphysical
28514442
VPS53_HUMANVPS53physical
28514442
RABX5_HUMANRABGEF1physical
28514442
KIF5A_HUMANKIF5Aphysical
28514442
CCDC6_HUMANCCDC6physical
28514442
VPS50_HUMANCCDC132physical
28514442
TRI32_HUMANTRIM32physical
28514442
EXOC5_HUMANEXOC5physical
28514442
KXDL1_HUMANKXD1physical
28514442
GIT2_HUMANGIT2physical
28514442
POTEE_HUMANPOTEEphysical
28514442
ARHG7_HUMANARHGEF7physical
28514442
SNAPN_HUMANSNAPINphysical
28514442
VPS51_HUMANVPS51physical
28514442
BL1S2_HUMANBLOC1S2physical
28514442
EXOC7_HUMANEXOC7physical
28514442
UBP4_HUMANUSP4physical
28514442
THA11_HUMANTHAP11physical
28514442
JUN_HUMANJUNphysical
28514442
EIPR1_HUMANTSSC1physical
28514442
CCHCR_HUMANCCHCR1physical
28514442
SIKE1_HUMANSIKE1physical
28514442
GIT1_HUMANGIT1physical
28514442
NUF2_HUMANNUF2physical
28514442
KINH_HUMANKIF5Bphysical
28514442
RABE1_HUMANRABEP1physical
28514442
TNIP1_HUMANTNIP1physical
28514442
GOGA5_HUMANGOLGA5physical
28514442
KIF5C_HUMANKIF5Cphysical
28514442
STRN3_HUMANSTRN3physical
28514442
STRN_HUMANSTRNphysical
28514442
PCNT_HUMANPCNTphysical
28514442
CC122_HUMANCCDC122physical
28514442
ZWINT_HUMANZWINTphysical
28514442
EXOC4_HUMANEXOC4physical
27173435
EXOC5_HUMANEXOC5physical
27173435
EIPR1_HUMANTSSC1physical
27173435
TMED1_HUMANTMED1physical
27173435
SNP29_HUMANSNAP29physical
27173435
EXOC6_HUMANEXOC6physical
27173435
EXOC7_HUMANEXOC7physical
27173435
EXOC8_HUMANEXOC8physical
27173435

Drug and Disease Associations
Kegg Disease
There are no disease associations of PTM sites.
OMIM Disease
There are no disease associations of PTM sites.
Kegg Drug
There are no disease associations of PTM sites.
DrugBank
There are no disease associations of PTM sites.
Regulatory Network of EXOC1_HUMAN

loading...

Related Literatures of Post-Translational Modification
Acetylation
ReferencePubMed
"Lysine acetylation targets protein complexes and co-regulates majorcellular functions.";
Choudhary C., Kumar C., Gnad F., Nielsen M.L., Rehman M., Walther T.,Olsen J.V., Mann M.;
Science 325:834-840(2009).
Cited for: ACETYLATION [LARGE SCALE ANALYSIS] AT LYS-5, AND MASS SPECTROMETRY.
Phosphorylation
ReferencePubMed
"Quantitative phosphoproteomic analysis of T cell receptor signalingreveals system-wide modulation of protein-protein interactions.";
Mayya V., Lundgren D.H., Hwang S.-I., Rezaul K., Wu L., Eng J.K.,Rodionov V., Han D.K.;
Sci. Signal. 2:RA46-RA46(2009).
Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-487 AND SER-501, ANDMASS SPECTROMETRY.
"Large-scale proteomics analysis of the human kinome.";
Oppermann F.S., Gnad F., Olsen J.V., Hornberger R., Greff Z., Keri G.,Mann M., Daub H.;
Mol. Cell. Proteomics 8:1751-1764(2009).
Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-470 AND THR-471, ANDMASS SPECTROMETRY.
"Lys-N and trypsin cover complementary parts of the phosphoproteome ina refined SCX-based approach.";
Gauci S., Helbig A.O., Slijper M., Krijgsveld J., Heck A.J.,Mohammed S.;
Anal. Chem. 81:4493-4501(2009).
Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-471 AND SER-473, ANDMASS SPECTROMETRY.
"A quantitative atlas of mitotic phosphorylation.";
Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,Elledge S.J., Gygi S.P.;
Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008).
Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-470 AND SER-473, ANDMASS SPECTROMETRY.

TOP